{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:42:00Z","timestamp":1793036520670,"version":"4.5.0"},"reference-count":138,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016242","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pulsed field ablation has emerged as a novel energy source for atrial fibrillation ablation, offering preferential myocardial ablation with a favourable safety profile. Contemporary paroxysmal AF clinical studies demonstrate 12-month freedom from atrial arrhythmia recurrence in approximately 75-85% of patients, with major complication rates generally ranging from 1 to 3%. Compared with thermal ablation, PFA offers comparable efficacy and streamlined procedural workflows. In persistent AF, PVI remains the foundation of ablation, while additional adjunctive strategies are increasingly evaluated. Current evidence suggests that PFA can achieve 12-month arrhythmia-free outcomes generally ranging from approximately 60-75% in persistent AF populations. Major procedure-related complications typically occur in &amp;lt;3% of cases, supporting the feasibility of broader lesion sets with an acceptable safety profile. However, the incremental benefit of adjunctive ablation beyond PVI and the optimal lesion set for persistent AF remain to be assessed further Outcome assessment after PFA requires consideration of evolving endpoints. The clinical relevance of the traditional post-ablation blanking period is being re-evaluated, while continuous rhythm monitoring and AF burden are increasingly incorporated alongside conventional recurrence endpoints. Patient-reported outcomes are an important component of PFA evaluation. Compared with thermal ablation, PFA is associated with improved procedural tolerability, reduced analgesic requirements, rapid recovery, and the potential for same-day discharge. These features, together with favourable efficacy and safety outcomes, may contribute to broader adoption of PFA across both paroxysmal and persistent AF populations.<\/jats:p>","DOI":"10.1093\/europace\/euag194","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:53:54Z","timestamp":1785243234000},"page":"ii99-ii117","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of paroxysmal and persistent atrial fibrillation with pulsed field ablation"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1280-7042","authenticated-orcid":false,"given":"Serge","family":"Boveda","sequence":"first","affiliation":[{"name":"Clinique Pasteur Heart Rhythm Management Department, , 45 Avenue de Lombez, 31300 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2355-6015","authenticated-orcid":false,"given":"Kyoung-Ryul Julian","family":"Chun","sequence":"additional","affiliation":[{"name":"CCB am Markus Krankenhaus Klinik fur Rhythmologie, , Wilhelm-Epstein 4, 60431 Frankfurt ,","place":["Germany"]},{"name":"Universitatsklinikum Schleswig-Holstein (UKSH) Klinik fur Rhythmologie, , Ratzeburger Allee 160, 23548 Lubeck ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4700-7811","authenticated-orcid":false,"given":"Pierre","family":"Jais","sequence":"additional","affiliation":[{"name":"CHU de Bordeaux Hopital Cardiologique du Haut-Leveque, , Avenue de Magellan, 33600 Pessac ,","place":["France"]},{"name":"IHU LIRYC Bordeaux University IHU LIRYC, , Av. du Haut Leveque, 33600 Pessac ,","place":["France"]},{"name":"American Hospital of Paris Cardiology Department, , 84 Boulevard de la Saussaye, 92200 Neuilly-Sur-Seine ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8236-1165","authenticated-orcid":false,"given":"Nicolas","family":"Johner","sequence":"additional","affiliation":[{"name":"CHU de Bordeaux Hopital Cardiologique du Haut-Leveque, , Avenue de Magellan, 33600 Pessac ,","place":["France"]},{"name":"IHU LIRYC Bordeaux University IHU LIRYC, , Av. du Haut Leveque, 33600 Pessac ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-3613","authenticated-orcid":false,"given":"Claire A","family":"Martin","sequence":"additional","affiliation":[{"name":"Royal Papworth Hospital Department of Cardiology, , Cambridge Biomedical Campus, Cambridge CB2 0AY ,","place":["United Kingdom"]},{"name":"University of Cambridge Department of Clinical Medicine, , Trinity Lane, Cambridge CB2 1TN ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9917-0401","authenticated-orcid":false,"given":"Rami","family":"Daya","sequence":"additional","affiliation":[{"name":"Boston Scientific Rhythm Management Medical Affairs, , Masaref Street, 13-6045 Beirut ,","place":["Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6327-0487","authenticated-orcid":false,"given":"Andrea","family":"Sarkozy","sequence":"additional","affiliation":[{"name":"Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel Heart Rhythm Management Centre, , 1090 Jette, Brussel ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"2026102613252702900_euag194-B1","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae043","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"26","author":"Tzeis","year":"2024","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B2","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae134","article-title":"State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective","volume":"26","author":"Chun","year":"2024","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B3","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae108","article-title":"Pre- and post-procedural cardiac imaging (computed tomography and magnetic resonance imaging) in electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and European Association of Cardiovascular Imaging of the European Society of Cardiology","volume":"26","author":"Deneke","year":"2024","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B4","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf156","article-title":"Sedation vs. general anaesthesia in patients with atrial fibrillation undergoing catheter ablation: a systematic review and meta-analysis","volume":"27","author":"Ara\u00fajo","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B5","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae301","article-title":"Comparative analysis of anaesthesia modalities in pulmonary vein isolation: insights from a prospective multicentre registry","volume":"27","author":"Massalha","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.126.014920","article-title":"Ablation of persistent atrial fibrillation using a dual-energy contact force-sensing catheter: topography of pulsed field mediated symptoms and new safety challenges","volume":"19","author":"Notaristefano","year":"2026","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B7","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae270","article-title":"General anaesthesia and deep sedation for monopolar pulsed field ablation using a lattice-tip catheter combined with a novel three-dimensional mapping system","volume":"26","author":"Rillig","year":"2024","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B8","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf287","article-title":"Characterization of sedation strategies in real-world use of pulsed field ablation Sub-analysis of the EU-PORIA registry","author":"Chun","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B9","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/europace\/euab154","article-title":"Worldwide sedation strategies for atrial fibrillation ablation: current status and evolution over the last decade","volume":"23","author":"Garcia","year":"2021","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B10","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf294","article-title":"Pulsed field ablation for atrial fibrillation ablation: a European Heart Rhythm Association survey","volume":"27","author":"Bergonti","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.125.013977","article-title":"2025 international expert practical guide on the use of the pentaspline pulsed field ablation system in atrial fibrillation ablation procedures","volume":"18","author":"Chen","year":"2025","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B12","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacep.2025.04.015","article-title":"Efficacy and drug-related complications of anticholinergic drugs for vagal reaction prevention during pulsed field ablation","volume":"11","author":"Vetta","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B13","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.hrthm.2024.01.040","article-title":"Pulsed field ablation of the right superior pulmonary vein prevents vagal responses via anterior right ganglionated plexus modulation","volume":"21","author":"Del Monte","year":"2024","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.010817","article-title":"5S study: safe and simple single shot pulmonary vein isolation with pulsed field ablation using sedation","volume":"15","author":"Schmidt","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B15","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/j.hrthm.2025.11.023","article-title":"First clinical experience using a pentaspline pulse field ablation catheter with integrated electroanatomic 3-dimensional mapping for pulmonary vein isolation","volume":"23","author":"Mitacchione","year":"2026","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B16","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf206","article-title":"Prevalence and multiple predictors of left atrial low voltage in paroxysmal and non-paroxysmal atrial fibrillation patients undergoing ablation: a systematic review and meta-analysis","volume":"27","author":"Oliva","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B17","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf012","article-title":"Repeat procedures after pulsed field ablation for atrial fibrillation: MANIFEST-REDO study","volume":"27","author":"Scherr","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B18","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa2307291","article-title":"Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation","volume":"389","author":"Reddy","year":"2023","journal-title":"N Engl J Med"},{"key":"2026102613252702900_euag194-B19","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa2502280","article-title":"Pulsed field or cryoballoon ablation for paroxysmal atrial fibrillation","volume":"392","author":"Reichlin","year":"2025","journal-title":"N Engl J Med"},{"key":"2026102613252702900_euag194-B20","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf019","article-title":"Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association","volume":"27","author":"Doehner","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B21","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad185","article-title":"EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry","volume":"25","author":"Schmidt","year":"2023","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCULATIONAHA.123.064959","article-title":"Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: one-year outcomes from the MANIFEST-PF registry","volume":"148","author":"Turagam","year":"2023","journal-title":"Circulation"},{"key":"2026102613252702900_euag194-B23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jacep.2025.02.026","article-title":"The olive strategy: improved pulmonary vein isolation durability with the pentaspline pulsed field catheter","volume":"11","author":"Schaack","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B24","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2025.10.084","article-title":"Pulsed-field ablation to enhance the durability of pulmonary vein isolation and treat paroxysmal atrial fibrillation","volume":"87","author":"Reddy","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"2026102613252702900_euag194-B25","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.hrthm.2025.04.031","article-title":"One-year outcomes of a conformable single-shot pulsed-field ablation catheter for the treatment of paroxysmal atrial fibrillation","volume":"22","author":"Reddy","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B26","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacep.2025.04.008","article-title":"PVI with CF-sensing large-tip focal PFA catheter with 3D mapping for paroxysmal AF: omny-IRE 3-month results","volume":"11","author":"Duytschaever","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B27","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf072","article-title":"Safety and effectiveness of the first balloon-in-basket pulsed field ablation system for the treatment of atrial fibrillation: VOLT CE Mark Study 6-month results","volume":"27","author":"Tilz","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B28","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.jacep.2023.04.002","article-title":"A focal ablation catheter toggling between radiofrequency and pulsed field energy to treat atrial fibrillation","volume":"9","author":"Reddy","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/pace.15177","article-title":"First experience using a novel variable loop catheter for mapping and pulsed field ablation of atrial fibrillation","volume":"48","author":"Fink","year":"2025","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B30","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/CIRCULATIONAHA.123.063988","article-title":"Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial","volume":"147","author":"Verma","year":"2023","journal-title":"Circulation"},{"key":"2026102613252702900_euag194-B31","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf174","article-title":"Dual energy for pulmonary vein isolation using focal ablation technology integrated with a three-dimensional mapping system: SmartfIRE 12-month results","volume":"27","author":"De Potter","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B32","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euag080","article-title":"Pulsed field ablation for the interventional treatment of atrial fibrillation: a scientific statement of the European Heart Rhythm Association of the European Society of Cardiology, the Heart Rhythm Society, the Asia Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society","volume":"28","author":"K\u00fchne","year":"2026","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B33","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf254","article-title":"European Heart Rhythm Association survey on the perceived severity of complications in atrial fibrillation ablation: development of a standardized scoring model","volume":"27","author":"Bordignon","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B34","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf210","article-title":"Haemolysis and myocardial and neural injury after monopolar pulsed field ablation using a novel lattice-tip catheter to treat atrial fibrillation","volume":"27","author":"Gold","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jacc.2025.10.051","article-title":"Multicenter study on the safety of pulsed field ablation in over 40,000 patients: MANIFEST-US","volume":"87","author":"Turagam","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"2026102613252702900_euag194-B36","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-025-02152-2","article-title":"Catheter design matters: hemolysis and renal function after pulsed field ablation with balloon-in-basket vs. pentaspline systems","author":"Wenzel","year":"2025","journal-title":"J Interv Card Electrophysiol"},{"key":"2026102613252702900_euag194-B37","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf185","article-title":"Incidence of laboratory-defined severe intravascular haemolysis across commercially available pulsed field ablation technologies for atrial fibrillation","volume":"27","author":"Mountantonakis","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCULATIONAHA.125.077983","article-title":"Life-threatening delayed myocardial ischemia and malignant arrhythmias occurring after pulsed field ablation of atrial fibrillation","volume":"153","author":"Gunawardene","year":"2026","journal-title":"Circulation"},{"key":"2026102613252702900_euag194-B39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/CIRCEP.123.011920","article-title":"Pulsed field versus cryoballoon pulmonary vein isolation for atrial fibrillation: efficacy, safety, and long-term follow-up in a 400-patient cohort","volume":"16","author":"Urbanek","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B40","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026102613252702900_euag194-B41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCULATIONAHA.125.074427","article-title":"COOPERATIVE-PFA: a three-arm randomized controlled trial","volume":"152","author":"Sochorov\u00e1","year":"2025","journal-title":"Circulation"},{"key":"2026102613252702900_euag194-B42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.125.074485","article-title":"Pulsed field ablation of persistent atrial fibrillation with continuous electrocardiographic monitoring follow-up: ADVANTAGE AF phase 2","volume":"152","author":"Reddy","year":"2025","journal-title":"Circulation"},{"key":"2026102613252702900_euag194-B43","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.hrthm.2024.04.045","article-title":"Pulsed-field vs cryoballoon vs radiofrequency ablation: outcomes after pulmonary vein isolation in patients with persistent atrial fibrillation","volume":"21","author":"Kueffer","year":"2024","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B44","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1016\/j.hrthm.2024.12.020","article-title":"Pentaspline catheter or cryoballoon for pulmonary vein plus posterior wall isolation in persistent atrial fibrillation: 1-year outcomes","volume":"22","author":"Pannone","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B45","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s10840-025-02078-9","article-title":"Acute outcomes of cryoballoon vs. circular vs. pentaspline pulsed-field ablation catheters in combined pulmonary vein isolation and roof line ablation","volume":"68","author":"Yogarajah","year":"2025","journal-title":"J Interv Card Electrophysiol"},{"key":"2026102613252702900_euag194-B46","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jacep.2023.03.021","article-title":"Pulsed-field ablation on mitral isthmus in persistent atrial fibrillation: preliminary data on efficacy and safety","volume":"9","author":"Davong","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B47","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jacep.2025.11.026","article-title":"Pulsed-field ablation on mitral isthmus with the pentaspline catheter","volume":"12","author":"Zaher","year":"2026","journal-title":"JACC Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2026.05.004","article-title":"Durability of atrial linear lesion sets using a dual-energy lattice-tip catheter: data from invasive remapping","author":"Nies","year":"2026","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B49","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/j.hrthm.2024.11.023","article-title":"Feasibility of atrial linear ablation using a lattice tip catheter that toggles between radiofrequency and pulsed-field energy under deep sedation","volume":"22","author":"Hirokami","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B50","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/s41591-024-03114-3","article-title":"Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study","volume":"30","author":"Ekanem","year":"2024","journal-title":"Nat Med"},{"key":"2026102613252702900_euag194-B51","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.123.012426","article-title":"Efficacy of intravenous nitrates for the prevention of coronary artery spasm during pulsed field ablation of the mitral isthmus","volume":"17","author":"Men\u00e8","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B52","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad371","article-title":"Severe acute kidney injury related to haemolysis after pulsed field ablation for atrial fibrillation","volume":"26","author":"Venier","year":"2023","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B53","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/s41591-024-03022-6","article-title":"Dual-energy lattice-tip ablation system for persistent atrial fibrillation: a randomized trial","volume":"30","author":"Anter","year":"2024","journal-title":"Nat Med"},{"key":"2026102613252702900_euag194-B54","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.hroo.2025.12.011","article-title":"A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: the AVANT GUARD trial rationale and design","volume":"7","author":"Wazni","year":"2026","journal-title":"Heart Rhythm O2"},{"key":"2026102613252702900_euag194-B55","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf326","article-title":"Controversy: pulsed field ablation is the standard technique for all the candidates for atrial fibrillation ablation","volume":"27","author":"Di Biase","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B56","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae006","article-title":"Posterior wall ablation by pulsed-field ablation: procedural safety, efficacy, and findings on redo procedures","volume":"26","author":"Kueffer","year":"2023","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B57","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae103","article-title":"Comparing pulsed field electroporation and radiofrequency ablation for the treatment of paroxysmal atrial fibrillation: design and rationale of the BEAT PAROX-AF randomized clinical trial","volume":"26","author":"Erhard","year":"2024","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B58","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/eurheartj\/ehaf1115","article-title":"Pulsed field vs radiofrequency ablation for paroxysmal atrial fibrillation: the BEAT PAROX-AF trial","volume":"47","author":"Jais","year":"2026","journal-title":"Eur Heart J"},{"key":"2026102613252702900_euag194-B59","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.hroo.2025.04.005","article-title":"Countrywide introduction of pulsed field ablation for the treatment of atrial fibrillation: acute results from the FRANCE-PFA registry","volume":"6","author":"Chaumont","year":"2025","journal-title":"Heart Rhythm O2"},{"key":"2026102613252702900_euag194-B60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1540-8159.2011.03256.x","article-title":"Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation","volume":"35","author":"Andrade","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B61","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003909","article-title":"Redefining the blanking period after catheter ablation for paroxysmal atrial fibrillation: insights from the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination) Trial","volume":"9","author":"Willems","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B62","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad173","article-title":"Identifying the prognostic significance of early arrhythmia recurrence during the blanking period and the optimal blanking period duration: insights from the DECAAF II study","volume":"25","author":"Noujaim","year":"2023","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B63","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jacep.2017.01.006","article-title":"Defining blanking period post-pulmonary vein antrum isolation","volume":"3","author":"Alipour","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B64","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.hrthm.2008.01.031","article-title":"Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation","volume":"5","author":"Themistoclakis","year":"2008","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B65","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/jce.16334","article-title":"Long-term clinical impact of early recurrence of atrial tachyarrhythmia after cryoballoon ablation in patients with atrial fibrillation","volume":"35","author":"Park","year":"2024","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026102613252702900_euag194-B66","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.hrthm.2021.06.1172","article-title":"Prevalence and outcome of early recurrence of atrial tachyarrhythmias in the Cryoballoon vs Irrigated Radiofrequency Catheter Ablation (CIRCA-DOSE) study","volume":"18","author":"Steinberg","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.hrthm.2025.09.026","article-title":"Impact of shortening the blanking period to 8 weeks after PVI: insights from COMPARE-CRYO using continuous rhythm monitoring","volume":"23","author":"Iqbal","year":"2026","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/CIRCEP.113.000876","article-title":"Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation","volume":"7","author":"Lim","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00392-011-0383-3","article-title":"Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation","volume":"101","author":"Richter","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"2026102613252702900_euag194-B70","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.jacc.2007.06.054","article-title":"Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data","volume":"50","author":"Issac","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026102613252702900_euag194-B71","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1161\/01.CIR.100.22.2237","article-title":"Alterations of heart rate variability after radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins","volume":"100","author":"Hsieh","year":"1999","journal-title":"Circulation"},{"key":"2026102613252702900_euag194-B72","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/europace\/euaa239","article-title":"Predictive role of early recurrence of atrial fibrillation after cryoballoon ablation","volume":"22","author":"Stabile","year":"2020","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B73","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.hrthm.2015.12.034","article-title":"Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: predictive role of atrial arrhythmias occurring in the blanking period on the incidence of late recurrences","volume":"13","author":"Mugnai","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B74","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.hrthm.2020.11.020","article-title":"Predictive value of atrial fibrillation during the postradiofrequency ablation blanking period","volume":"18","author":"Calkins","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B75","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/europace\/euab155","article-title":"Pulsed field ablation prevents chronic atrial fibrotic changes and restrictive mechanics after catheter ablation for atrial fibrillation","volume":"23","author":"Nakatani","year":"2021","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B76","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.010661","article-title":"Time course of irreversible electroporation lesion development through short- and long-term follow-up in pulsed-field ablation-treated hearts","volume":"15","author":"Grimaldi","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B77","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/jce.15352","article-title":"Characteristics and time course of acute and chronic myocardial lesion formation after electroporation ablation in the porcine model","volume":"33","author":"Neven","year":"2022","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026102613252702900_euag194-B78","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007781","article-title":"Preclinical evaluation of pulsed field ablation: electrophysiological and histological assessment of thoracic vein isolation","volume":"12","author":"Koruth","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B79","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/europace\/euz341","article-title":"Endocardial ventricular pulsed field ablation: a proof-of-concept preclinical evaluation","volume":"22","author":"Koruth","year":"2020","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B80","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1111\/jce.16083","article-title":"Early recurrences predict late therapy failure after pulsed field ablation of atrial fibrillation","volume":"34","author":"Plank","year":"2023","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026102613252702900_euag194-B81","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf007","article-title":"Early versus late atrial fibrillation recurrence after pulsed field ablation: insights from the admIRE trial","volume":"27","author":"Di Biase","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B82","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/jce.16670","article-title":"Insight into early recurrences after pulsed-field ablation for atrial fibrillation: results from a multicenter experience","volume":"36","author":"Bisignani","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026102613252702900_euag194-B83","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.hrthm.2024.08.011","article-title":"Redefining the blanking period after pulsed field ablation in patients with atrial fibrillation","volume":"22","author":"Mohanty","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B84","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2024.06.036","article-title":"Prevalence, timing, and impact of early recurrence of atrial tachyarrhythmias after pulsed field ablation: a secondary analysis of the PULSED AF trial","volume":"22","author":"Boersma","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B85","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033146","article-title":"Pentaspline pulsed field ablation catheter versus cryoballoon for atrial fibrillation ablation: results from a prospective comparative study","volume":"13","author":"Chaumont","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026102613252702900_euag194-B86","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.124.013088","article-title":"Pulsed field ablation as first-line therapy for atrial fibrillation: a substudy of the EU-PORIA registry","volume":"17","author":"F\u00fcting","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B87","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf203","article-title":"Controversy: the blanking period after atrial fibrillation ablation is needed and should be maintained","volume":"27","author":"P\u00fcrerfellner","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B88","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.124.013456","article-title":"Doubts on) the mechanistic role of pulmonary veins reconnection in paroxysmal and persistent atrial fibrillation: a meta-analysis of mandatory remapping studies","volume":"18","author":"Bergonti","year":"2025","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B89","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ipej.2025.08.005","article-title":"Catheter ablation of atrial fibrillation: time to look beyond iterative pulmonary vein isolation only and \u201cone-size-fits-all\u201d strategies","volume":"25","author":"Johner","year":"2025","journal-title":"Indian Pacing Electrophysiol J"},{"key":"2026102613252702900_euag194-B90","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jacep.2021.02.014","article-title":"Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II","volume":"7","author":"Reddy","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B91","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.122.011780","article-title":"Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspIRE study","volume":"16","author":"Duytschaever","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B92","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCULATIONAHA.124.070333","article-title":"Pulsed field ablation to treat paroxysmal atrial fibrillation: safety and effectiveness in the AdmIRE pivotal trial","volume":"150","author":"Reddy","year":"2024","journal-title":"Circulation"},{"key":"2026102613252702900_euag194-B93","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.124.012794","article-title":"Pulsed field ablation using focal contact force-sensing catheters for treatment of atrial fibrillation: 1-year outcomes of the ECLIPSE AF study","volume":"18","author":"Ani\u0107","year":"2025","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B94","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae088","article-title":"Dual energy for pulmonary vein isolation using dual-energy focal ablation technology integrated with a three-dimensional mapping system: SmartfIRE 3-month results","volume":"26","author":"Duytschaever","year":"2024","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B95","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacep.2025.04.008","article-title":"PVI with CF-sensing large-tip focal PFA catheter with 3D mapping for paroxysmal AF","volume":"11","author":"Duytschaever","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B96","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.hrthm.2024.04.102","article-title":"AF ablation using a novel \u201csingle-shot\u201d map-and-ablate spherical array pulsed field ablation catheter: 1-year outcomes of the first-in-human PULSE-EU trial","volume":"21","author":"Turagam","year":"2024","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B97","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.hrthm.2025.04.042","article-title":"Sine wave electroporation in patients with atrial fibrillation: initial results of the BURST-AF study","volume":"22","author":"Anic","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B98","first-page":"S548","article-title":"PO-05-158 First-in-human clinical experience of pulse field ablation using nanosecond pulses to treat atrial fibrillation","volume":"21","author":"Reddy","year":"2024","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B99","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad335","article-title":"Durability of pulmonary vein isolation for atrial fibrillation: a meta-analysis and systematic review","volume":"25","author":"Serban","year":"2023","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B100","doi-asserted-by":"crossref","first-page":"e831","DOI":"10.1016\/j.hrthm.2025.12.016","article-title":"Pulsed-field ablation demonstrates superior pulmonary vein isolation durability at 90 days: pooled analysis of protocol-mandated remapping data","volume":"23","author":"Briosa e Gala","year":"2026","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B101","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jacep.2023.11.026","article-title":"Durability of pulmonary vein isolation using pulsed-field ablation: results from the multicenter EU-PORIA registry","volume":"10","author":"Kueffer","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B102","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae016","article-title":"Pulsed electric field, cryoballoon, and radiofrequency for paroxysmal atrial fibrillation ablation: a propensity score-matched comparison","volume":"26","author":"Della Rocca","year":"2023","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B103","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.125.074485","article-title":"Pulsed field ablation of persistent atrial fibrillation with continuous ECG monitoring follow-up: ADVANTAGE AF-phase 2","volume":"152","author":"Reddy","year":"2025","journal-title":"Circulation"},{"key":"2026102613252702900_euag194-B104","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/jama.2022.23722","article-title":"Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial","volume":"329","author":"Kistler","year":"2023","journal-title":"JAMA"},{"key":"2026102613252702900_euag194-B105","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1016\/j.jacep.2025.08.021","article-title":"Microanatomy of the posterior mitral isthmus region: implications for the cardiac electrophysiologist","volume":"8","author":"Delgove","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B106","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.hrthm.2021.06.1202","article-title":"Epicardial course of the musculature related to the great cardiac vein: anatomical considerations and clinical implications for mitral isthmus block after vein of Marshall ethanol infusion","volume":"18","author":"Pambrun","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B107","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.125.014026","article-title":"Feasibility and safety of pulsed field ablation for coronary sinus and left atrial appendage isolation and mitral isthmus ablation: acute and chronic findings","volume":"18","author":"La Fazia","year":"2025","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B108","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1016\/j.hrthm.2025.05.045","article-title":"Ensuring catheter-tissue contact with intracardiac echocardiography during pulsed-field ablation improves procedure outcome in patients with atrial fibrillation","volume":"22","author":"Mohanty","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B109","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf009","article-title":"First-in-human trial of atrial fibrillation ablation using real-time tissue optical assessment to predict pulsed field lesion durability","volume":"27","author":"Martins","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B110","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.125.013911","article-title":"Real-time prediction of irreversible lesion size during pulsed field ablation: prospective validation of a novel ablation index based on contact force and number of applications in a swine beating heart model","volume":"18","author":"Nakagawa","year":"2025","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B111","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/ehac692","article-title":"Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study","volume":"44","author":"Andrade","year":"2023","journal-title":"Eur Heart J"},{"key":"2026102613252702900_euag194-B112","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacep.2020.11.021","article-title":"Atrial fibrillation burden and clinical outcomes in heart failure: the CASTLE-AF trial","volume":"7","author":"Brachmann","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B113","article-title":"Atrial fibrillation burden, episode duration and frequency in relation to quality of life in patients with implantable cardiac monitor","volume":"34","author":"Jansson","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2026102613252702900_euag194-B114","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25473","article-title":"Association between quality of life and procedural outcome after catheter ablation for atrial fibrillation: a secondary analysis of a randomized clinical trial","volume":"3","author":"Terricabras","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026102613252702900_euag194-B115","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.010304","article-title":"Arrhythmic burden and the risk of cardiovascular outcomes in patients with paroxysmal atrial fibrillation and cardiac implanted electronic devices","volume":"15","author":"Chew","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B116","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.124.012842","article-title":"Temporal association between atrial fibrillation burden in cardiac implantable electronic devices and the risk of heart failure hospitalization","volume":"17","author":"Ahluwalia","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B117","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.hrthm.2021.01.021","article-title":"Atrial fibrillation burden and heart failure: data from 39,710 individuals with cardiac implanted electronic devices","volume":"18","author":"Steinberg","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B118","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/STROKEAHA.110.609297","article-title":"Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring","volume":"42","author":"Boriani","year":"2011","journal-title":"Stroke"},{"key":"2026102613252702900_euag194-B119","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"key":"2026102613252702900_euag194-B120","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1161\/CIRCULATIONAHA.119.041303","article-title":"Stroke risk as a function of atrial fibrillation duration and CHA2DS2-VASc score","volume":"140","author":"Kaplan","year":"2019","journal-title":"Circulation"},{"key":"2026102613252702900_euag194-B121","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2024.05.001","article-title":"Pulsed field vs conventional thermal ablation for paroxysmal atrial fibrillation: recurrent atrial arrhythmia burden","volume":"84","author":"Reddy","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026102613252702900_euag194-B122","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.hrthm.2023.05.018","article-title":"Influence of monitoring and atrial arrhythmia burden on quality of life and health care utilization in patients undergoing pulsed field ablation: a secondary analysis of the PULSED AF trial","volume":"20","author":"Verma","year":"2023","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B123","first-page":"1664","article-title":"Pulsed field ablation for persistent atrial fibrillation: 1-year results of ADVANTAGE AF","volume":"85","author":"Reddy","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026102613252702900_euag194-B124","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jacc.2019.04.021","article-title":"Pulsed field ablation for pulmonary vein isolation in atrial fibrillation","volume":"74","author":"Reddy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026102613252702900_euag194-B125","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008716","article-title":"Focal pulsed field ablation for pulmonary vein isolation and linear atrial lesions: a preclinical assessment of safety and durability","volume":"13","author":"Koruth","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026102613252702900_euag194-B126","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf085.383","article-title":"Sedation protocols for atrial fibrillation ablation using pulsed-field ablation: patient and operator-reported outcomes from a large nationwide study","volume":"27","author":"Carboni","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B127","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s10840-025-02050-7","article-title":"Feasibility of deep sedation for catheter ablation of atrial fibrillation using pulsed field ablation","volume":"68","author":"Patel","year":"2025","journal-title":"J Interv Card Electrophysiol"},{"key":"2026102613252702900_euag194-B128","article-title":"Sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration","volume":"25","author":"Iacopino","year":"2023","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B129","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad222","article-title":"Deep sedation protocol during atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter","volume":"25","author":"Grimaldi","year":"2023","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B130","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s10840-024-01961-1","article-title":"Feasibility of pulsed field ablation for atrial fibrillation under mild conscious sedation","volume":"68","author":"Calvert","year":"2025","journal-title":"J Interv Card Electrophysiol"},{"key":"2026102613252702900_euag194-B131","first-page":"1614","article-title":"Pulsed-field versus cryoballoon ablation for atrial fibrillation\u2014impact of energy source on sedation and analgesia requirement","volume":"34","author":"Grimaldi","year":"2024","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026102613252702900_euag194-B132","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.jacep.2025.03.019","article-title":"HRS\/ACC scientific statement: guiding principles on same-day discharge for intracardiac catheter ablation procedures","volume":"11","author":"Shanker","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B133","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae200","article-title":"Same-day discharge vs. overnight stay following catheter ablation for atrial fibrillation: a comprehensive review and meta-analysis by the European Heart Rhythm Association Health Economics Committee","volume":"26","author":"Zylla","year":"2024","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B134","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf270","article-title":"Procedural characteristics and clinical outcomes from same-day discharge after pulsed field ablation treatment for atrial fibrillation: an admIRE trial sub-analysis","volume":"27","author":"Di Biase","year":"2025","journal-title":"Europace"},{"key":"2026102613252702900_euag194-B135","doi-asserted-by":"crossref","first-page":"S384","DOI":"10.1016\/j.hrthm.2025.03.1027","article-title":"Comparison of 30-day readmission and same-day discharge rates in patients undergoing pulsed field vs radiofrequency ablation for atrial fibrillation: a multicenter analysis","volume":"22","author":"Garapati","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026102613252702900_euag194-B136","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/pace.70005","article-title":"Safety of same-day discharge following pulsed-field ablation versus radiofrequency ablation: a comparative analysis","volume":"48","author":"Watfa","year":"2025","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026102613252702900_euag194-B137","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ahj.2017.12.007","article-title":"The optimal anti-coagulation for enhanced-risk patients post\u2013catheter ablation for atrial fibrillation (OCEAN) trial","volume":"197","author":"Verma","year":"2018","journal-title":"Am Heart J"},{"key":"2026102613252702900_euag194-B138","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10840-024-01912-w","article-title":"Safety, efficacy, and quality of life outcomes of pulsed field ablation in Japanese patients with atrial fibrillation: results from the PULSED AF trial","volume":"68","author":"Yamane","year":"2025","journal-title":"J Interv Card Electrophysiol"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/Supplement_2\/ii99\/72257421\/euag194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/Supplement_2\/ii99\/72257421\/euag194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:25:48Z","timestamp":1793035548000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/28\/Supplement_2\/ii99\/8965211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":138,"journal-issue":{"issue":"Supplement_2","published-print":{"date-parts":[[2026,10,21]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euag194","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,10]]}}}